Last reviewed · How we verify
Atrophic vaginitis
Approved treatments
- Micronor · Johnson & Johnson
ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects. - Estrace · Pfizer
Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen. - Femring · Apil
Estrogens, primarily estradiol, bind to nuclear receptors in estrogen-responsive tissues, modulating the female reproductive system and reducing postmenopausal gonadotropin levels. - Depo-Provera · Pfizer
Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy. - Ogen .625 · Pfizer
- Endometrin · Ferring
- Synestrol · Johnson & Johnson
- Ortho-Novum 10/11-21 · Merck & Co.
- Estring · Pfizer Inc.
Prevents pregnancy primarily by suppressing ovulation. - Slynd · Exeltis Usa Inc
Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation. - Progesteron · Minia University
Clinical guidelines
- FDA label — 1L
Estring (estradiol) is indicated for the treatment of atrophic vaginitis. - FDA label — 1L
Estring (estradiol) is indicated for the treatment of atrophic changes of the vulva. - FDA label — 1L
Estring (estradiol) is indicated for the treatment of female hypogonadism syndrome. - FDA label — 1L
Estring (estradiol) is indicated for the treatment of menopausal flushing.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Atrophic vaginitis patent landscape — cliff calendar, originator estates, attackable patents
- Atrophic vaginitis treatment landscape brief
- Atrophic vaginitis treatment updates RSS
Frequently asked questions about Atrophic vaginitis
What drugs treat Atrophic vaginitis?
Tracked treatments include Micronor, Estrace, Femring, Depo-Provera, Ogen .625, Endometrin, Synestrol, Ortho-Novum 10/11-21.
What is the treatment for Atrophic vaginitis?
Standard treatment for Atrophic vaginitis includes Micronor, Estrace, Femring, Depo-Provera, Ogen .625. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Atrophic vaginitis?
FDA label publishes guidelines for Atrophic vaginitis. 4 guideline references tracked.
Related
- Treatment landscape: Atrophic vaginitis patent cliff · Atrophic vaginitis CI report
- Treatment: Micronor · Johnson & Johnson
- Treatment: Estrace · Pfizer
- Treatment: Femring · Apil
- Treatment: Depo-Provera · Pfizer
- Treatment: Ogen .625 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing